# Tesamorelin - Tesamorelin / TH9507, a stabilised GHRH(1-44) analog supplied freeze-dried as research reference material. Tesamorelin (TH9507) GHRH analog research-use-only material - freeze-dried, historical sample report on file, dispatched from Perth. ## At a glance | | | | --- | --- | | Compound | Tesamorelin | | Descriptor | GHRH analog studied in growth-hormone-axis research | | Current certificate | Not verified for listed lot | | Storage | 2-8 C | | Format | Freeze-dried powder | | Availability | Out of stock | | Lot | TESA-2506 | ## Sizes and pricing (AUD) | | | | --- | --- | | 10 mg | $249 AUD | ## Certificate status Matching current certificate unavailable. No verified report matches the listed compound, lot and amount. Historical sample report: Tesamorelin, 5 mg, lot FL20260410-TESA-5. Test: Peptide vial assessment. This report does not verify the listed item or lot; a document mismatch does not establish the physical product's contents. ## What Tesamorelin is Tesamorelin is also known as TH9507. It is a synthetic, stabilised analog of GHRH(1-44), meaning the full 44-amino-acid growth-hormone-releasing hormone sequence with a trans-3-hexenoic acid cap on one end. The same molecule is the active ingredient in Egrifta, an FDA-approved prescription medicine for excess visceral abdominal fat in people with HIV-associated lipodystrophy. Form Laboratories does not sell Egrifta or any medicine; this listing is research-use-only reference material of the molecule, not the medicine, not for human use. Matching current certification is unavailable for TESA-2506. The historical 5 mg assessment covers FL20260410-TESA-5, not the listed 10 mg item or lot. ## Specifications Use this section to confirm the basics: research code, CAS, formula, molecular weight, format, storage, and current lot. A matching current certificate is unavailable; available sample reports cover only their named samples. | | | | --- | --- | | Compound | Tesamorelin | | Research code | TH9507 / TH-9507 | | CAS | 218949-48-5 | | Molecular formula | C221H366N72O67S | | Molecular weight | 5135.86 Da | | Structure note | N-[(3E)-hex-3-enoyl]-GHRH(1-44) | | Format | Freeze-dried research reference | | Storage | 2-8 C, protect from light | | Lot | TESA-2506 | ## What Tesamorelin studies look at Published papers describe TH9507 as an agonist at the GHRH receptor. In that literature, GHRH means growth-hormone-releasing hormone, GH means growth hormone, and IGF-1 is a downstream marker researchers measure. The pivotal human trials studied tesamorelin in people with HIV-associated lipodystrophy and reported visceral-fat changes against placebo. Those figures are published trial findings about the molecule, not Form Laboratories product claims. Lot release stays separate from the papers. The historical sample report does not establish current identity, purity or release status. ## Frequently asked questions ### What is Tesamorelin supplied for? Tesamorelin is supplied as laboratory research material only. It is 21+ only, not for human consumption, and not for veterinary use. ### Does this page include matching COA information? The product page lists catalog lot, appearance and storage notes for Tesamorelin. Available original reports are labelled by sample; matching current certification is unavailable where the compound, lot or amount differs. A heavy-metals screen does not measure purity or confirm identity. ### How should the vial be handled after delivery? Follow the label and your laboratory's written procedures. Do not treat a historical sample report as current lot documentation. This page repeats 2-8 C storage guidance and light-protection notes before checkout. ### What is Tesamorelin? Tesamorelin is a lab-made peptide known in research as TH9507, a stabilised analog of growth-hormone-releasing hormone. Form Laboratories supplies it freeze-dried as reference material for laboratory research. ### Is Tesamorelin the same as Egrifta? Tesamorelin is the active molecule in Egrifta, an FDA-approved prescription medicine. Form Laboratories does not sell Egrifta or any medicine; this material is research-use-only reference material of the molecule, not the approved drug, not for human use. ### Is this for human use? No. Tesamorelin from Form Laboratories is supplied strictly as reference material for laboratory research, not a medicine, supplement, or food, and not for people or animals to take. Even though the same molecule is an approved prescription medicine elsewhere as Egrifta, this material is not that medicine and is not for human use. ## References - Ferdinandi 2007: Ferdinandi ES et al. Basic Clin Pharmacol Toxicol. 2007;100(1):49-58. DOI: 10.1111/j.1742-7843.2007.00008.x - Dhillon 2011: Dhillon S. Drugs. 2011;71(8):1071-1091. DOI: 10.2165/11202240-000000000-00000 - Fourman 2020: Fourman LT et al. JCI Insight. 2020;5(16):e140134. DOI: 10.1172/jci.insight.140134 This summary is for scientific and educational context only. It is not preparation guidance, administration guidance, or a statement about use in people or animals. --- Canonical page: https://www.formlaboratories.com/shop/tesamorelin Form Laboratories - Perth-based research-use-only peptide supplier, shipping Australia-wide. - Site guide for agents: https://www.formlaboratories.com/llms.txt - Sitemap: https://www.formlaboratories.com/sitemap.xml - Full catalogue: https://www.formlaboratories.com/shop - Contact: hello@formlaboratories.com All materials are supplied for laboratory research use only - not for human or veterinary use, and nothing on this site is medical advice.